Free weekly newsletter

Get the free weekly executive digest

The new leadership moves, who’s behind them, and what they mean — delivered to your inbox every week. No credit card, unsubscribe anytime.

Weekly Digest

New leadership moves, summarized for you

Straight to Inbox

No login, no app to check — it comes to you

Leadership Trends

See who's moving and how much in your market

No credit card required Weekly executive digest

Plexium, Inc. Appoints Jorge F. Di Martino, M.D., Ph.D. As Chief Medical Officer and Executive Vice President of Clinical and Translational Development

PRIVATEOct 01, 2024•over 1 year ago

Position

Chief Medical Officer

Company

Plexium

Jorge F. DiMartino

San DiegoBiotechnologyHealth Care

Description

Plexium, Inc. today announced the appointment of Jorge F. DiMartino, M.D., Ph.D., as Chief Medical Officer and Executive Vice President of Clinical and Translational Development

Company Information

Company

Plexium

Location

San Diego, California, United States

About

Plexium is the premier, next-generation targeted protein degradation company, seeking to discover a wide range of monovalent target protein degraders that address the limitations of PROTACs and cereblon. The company’s platform is a proprietary drug discovery platform designed to identify novel small molecules that induce selective degradation of drug target proteins through E3 ligase mediated proteasomal degradation. From molecular glues to monovalent degraders, Plexium is advancing a pipeline of novel targeted protein degraders for the treatment of cancer, neurodegeneration, and other diseases.

Related People

Suggested for you

Choose your plan to reveal verified contacts

Predictive Intelligence

Strategic

ML-powered predictions for Plexium's next move

Learn about Strategic plan

Executive Insights

Based on hiring data

New executive impact window

87% of new executives make significant technology decisions within first 100 days

Budget influence

C-level executives control 73% of technology spending decisions

Transformation catalyst

65% of new senior hires launch digital transformation initiatives

Vendor review timeline

New executives typically review existing vendors within 6 months